Health News-RSS Feeds

Subscribe to Health News-RSS Feeds feed Health News-RSS Feeds
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
Updated: 40 min 25 sec ago

Vaping tied to higher risk that teens will try marijuana

April 24, 2018 - 12:29am
(Reuters Health) - Teens who use e-cigarettes may be twice as likely to smoke pot as their peers who never try vaping, a U.S. study suggests.

Wounded soldier gets world's first penis transplant in U.S. operation

April 24, 2018 - 12:22am
(Reuters) - A soldier wounded by an improvised explosive device in Afghanistan has received the world's first complete penis and scrotum transplant, officials at Johns Hopkins Hospital in Baltimore said on Monday.

Gender bias in peer review of research grants may penalize women

April 23, 2018 - 11:00pm
(Reuters Health) - Female researchers may be less successful at winning grant funding than their male counterparts with similar experience and qualifications at least in part because of gender bias among reviewers, a Canadian study suggests.

Jilted Akorn sues Fresenius over deal termination

April 23, 2018 - 8:20pm
FRANKFURT (Reuters) - U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $4.75 billion takeover agreement.

Trump delays drug pricing speech, no set date yet

April 23, 2018 - 7:46pm
WASHINGTON (Reuters) - U.S. President Donald Trump has postponed a speech on lowering prescription drug prices previously scheduled for Thursday to a date in the near future, the White House said on Sunday.

Trump delays drug pricing speech, no set date yet

April 23, 2018 - 7:44pm
WASHINGTON (Reuters) - U.S. President Donald Trump has postponed a speech on lowering prescription drug prices previously scheduled for Thursday to a date in the near future, the White House said on Sunday.

Woodford-backed biotech Prothena plunges as key drug fails

April 23, 2018 - 7:29pm
LONDON (Reuters) - Shares in Prothena, a biotech company backed by British investor Neil Woodford, plunged 70 percent on Monday after its main drug for treating a rare disease called AL amyloidosis failed in a crucial clinical trial.

FDA declines to approve Pfizer biosimilar of Roche's cancer drug

April 23, 2018 - 5:58pm
(Reuters) - Pfizer Inc said on Monday U.S. regulators declined to approve the company's biosimilar of Roche's blockbuster treatment for breast cancer, Herceptin, and sought additional technical information.

FDA declines to approve Pfizer's biosimilar to Roche's cancer drug

April 23, 2018 - 5:28pm
(Reuters) - Pfizer Inc said on Monday the U.S. Food and Drug Administration (FDA) declined to approve the company's biosimilar to Roche's breast cancer drug, Herceptin, and sought additional technical information.

World's 'oldest person' dies in Japan aged 117

April 22, 2018 - 12:06pm
TOKYO (Reuters) - A Japanese woman born in the final year of the 19th century and believed to have been the world's oldest person died on Saturday, Kyodo news agency said. She was 117.

Many approaches may help children improve self-regulation

April 21, 2018 - 2:06am
(Reuters Health) - Yoga, exercise, education and personal skills training are among the many types of interventions that may help kids improve what's known as self-regulation, or their ability to manage their behavior and emotions, a study suggests.

Opioids overprescribed to patients taking certain sedatives

April 21, 2018 - 1:41am
(Reuters Health) - Narcotic painkillers can be particularly dangerous for patients who also take tranquilizing drugs known as benzodiazepines, but a study suggests doctors are still over-prescribing this combination of medicines.

Hungarian laboratory worker isolated after exposure to Ebola virus

April 21, 2018 - 1:36am
BUDAPEST (Reuters) - A Hungarian laboratory worker has been isolated at a Budapest hospital after accidental exposure to the deadly Ebola virus but has shown no symptoms so far, health officials said on Friday.

Many U.S. kids with brain injuries not getting needed rehab

April 21, 2018 - 12:46am
(Reuters Health) - Many children hospitalized in the U.S. for brain injuries don't receive all the rehabilitation services needed for them to potentially make a full recovery, a new study suggests.

U.S. biotech companies Alnylam, Dicerna settle trade secrets case

April 20, 2018 - 11:25pm
BOSTON (Reuters) - Alnylam Pharmaceuticals Inc said on Friday that Dicerna Pharmaceuticals Inc will pay it $25 million in cash and stock to resolve a lawsuit claiming it stole trade secrets about gene-silencing technology used to develop drug treatments.

Losing a spouse late in life linked to cognitive decline

April 20, 2018 - 8:12pm
(Reuters Health) - Older adults who lose a spouse may be more vulnerable to cognitive decline in subsequent years and require extra support and monitoring, researchers say.

Germany's Merck seeks partners for cancer and immune system drugs

April 20, 2018 - 6:44pm
FRANKFURT (Reuters) - Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing deals to help fund clinical trials, according to its head of drug R&D.

Biogen boosts investment in neurology with $1 billion Ionis deal

April 20, 2018 - 5:34pm
(Reuters) - U.S. drugmaker Biogen Inc rolled out part of its $37 billion investment warchest on Friday, signing a $1 billion deal that seeks to expand on the strength of an existing partnership with Ionis Pharmaceuticals Inc.

U.S. appeals court blocks Indiana 'selective' abortion law

April 20, 2018 - 6:07am
(Reuters) - A federal appeals court on Thursday declared unconstitutional an Indiana law signed by then-Governor Mike Pence that banned women from having abortions because of the gender, race or disability, including Down's syndrome, of their fetuses.

Improving overall heart health may reduce risk of atrial fibrillation

April 20, 2018 - 12:44am
(Reuters Health) - Following practices recommended for "optimal" heart health may also reduce the risk of developing a serious heart-rhythm disorder, researchers say.